Pregnancy monitoring belt pilot study
Part of Women’s health & pregnancy clinical trials.
This study tests a new belt that monitors pregnancy. The goal is to see if it works well and is easy to use. Pregnant women and their healthcare providers can join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 29 weeks pregnant (29 weeks + 0 days or more).
- You are carrying a single baby (not twins or more).
- You are 18 years old or older.
- You can take part in a study conducted in Finnish language.
- Or you are a healthcare professional who works with pregnant women and can take part in Finnish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new wearable device to monitor your baby's heart activity during pregnancy. It aims to see if this device works well for both low and high-risk pregnancies to detect any heart issues early.
This trial lets you monitor your baby's heartbeat at home with a simple device instead of coming to the hospital each time. It's for women with certain high-risk pregnancy conditions who are 32 weeks or more along.
This study looks at what information pregnant people and their partners need during pregnancy, and how wearable devices (like fitness trackers) might help. You'd use a smartphone app to answer questions about your pregnancy experience and information needs.
This trial is testing a new system called Femom, which monitors your baby's heartbeat during pregnancy, to see if it works as well as the standard method. If you're at least 32 weeks pregnant with one baby, you may be able to join.
This trial tests a remote digital care system to monitor your pregnancy at home if you have a complication that requires regular CTG (fetal heartbeat) checks. The goal is to see if this home monitoring is safe and accessible, reducing the need for hospital visits.
This trial tests whether a home monitoring device linked to a telehealth platform can safely reduce the number of in-person fetal nonstress tests (NSTs) needed for pregnant people with certain conditions. It may help you by offering more convenient monitoring between 32 and 40 weeks of pregnancy.
Hear when a new Validation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.